Association of caffeine intake with all-cause and cardiovascular mortality in diabetes and prediabetes
- PMID: 39061109
- PMCID: PMC11282651
- DOI: 10.1186/s13098-024-01417-6
Association of caffeine intake with all-cause and cardiovascular mortality in diabetes and prediabetes
Abstract
Backgroud: The association between caffeine intake and mortality in prediabetes and diabetes is not well defined. This study was designed to investigate the association between caffeine intake and all-cause mortality and cardiovascular disease (CVD) mortality in adults with prediabetes and diabetes in the United States.
Methods: This analysis included 18,914 adult patients with diabetes and prediabetes from the National Health and Nutrition Examination Survey (NHANES) 2003-2018. Follow-up extended to December 31, 2019. Weighted Cox proportional hazards regression models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CI) for all-cause mortality and CVD mortality.
Results: During 142,460 person-years of follow-up, there were 3,166 cases of all-cause mortality and 1,031 cases of CVD mortality recorded. In the fully adjusted models, caffeine intake showed a significant dose-response association with the risk of all-cause mortality and CVD mortality in individuals with diabetes and prediabetes. When comparing extreme quartiles of caffeine intake, the multivariable-adjusted hazard ratio for all-cause mortality was 0.78 (0.67-0.91) (P for trend = 0.007); however, there was no significant association with the risk of CVD mortality. Results remained consistent in stratified analyses by sex, age, race/ethnicity, education level, family income-poverty ratio, BMI, hypertension, smoking status, alcohol intake, and HEI-2015.
Conclusions: This study suggests that caffeine intake is significantly inversely associated with the risk of all-cause mortality in individuals with diabetes and prediabetes. In individuals with prediabetes, there is also a significant inverse association between caffeine intake and CVD events, but this association is not present in those with diabetes.
Keywords: Caffeine; Diabetes; Mortality; NHANES; Predibetes.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
The Role of Xenobiotic Caffeine on Cardiovascular Health: Promises and Challenges.J Xenobiot. 2025 Mar 31;15(2):51. doi: 10.3390/jox15020051. J Xenobiot. 2025. PMID: 40278156 Free PMC article. Review.
-
Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in US adults with diabetes and prediabetes: a prospective cohort study.BMC Endocr Disord. 2024 May 10;24(1):64. doi: 10.1186/s12902-024-01592-7. BMC Endocr Disord. 2024. PMID: 38730476 Free PMC article.
-
Associations of healthy lifestyle and family income to poverty ratio with all-cause mortality among people with prediabetes and diabetes: a prospective cohort study.BMC Public Health. 2025 Jan 3;25(1):24. doi: 10.1186/s12889-024-21206-0. BMC Public Health. 2025. PMID: 39754064 Free PMC article.
-
Association between Caffeine Intake and All-Cause and Cause-Specific Mortality: An Analysis of the National Health and Nutrition Examination Survey (NHANES) 1999-2014 Database.Nurs Rep. 2021 Nov 10;11(4):901-912. doi: 10.3390/nursrep11040083. Nurs Rep. 2021. PMID: 34968277 Free PMC article.
-
MORTALITY AND CARDIOVASCULAR RISK REDUCTION AFTER REVERSION OF PREDIABETES TO NORMOGLYCEMIA: A SYSTEMATIC REVIEW.Acta Endocrinol (Buchar). 2024 Jan-Mar;20(1):74-79. doi: 10.4183/aeb.2024.74. Epub 2024 Oct 3. Acta Endocrinol (Buchar). 2024. PMID: 39372294 Free PMC article. Review.
Cited by
-
The Role of Xenobiotic Caffeine on Cardiovascular Health: Promises and Challenges.J Xenobiot. 2025 Mar 31;15(2):51. doi: 10.3390/jox15020051. J Xenobiot. 2025. PMID: 40278156 Free PMC article. Review.
References
-
- Magliano DJ, Boyko EJ. IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS (internet). 10th ed. Brussels: International Diabetes Federation; 2021. p. 35914061.
-
- Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC, ESC Scientific Document Group. diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323. 2019 ESC Guidelines on. 10.1093/eurheartj/ehz486 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources